Middle East & Africa Biopharmaceuticals Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Biopharmaceuticals Market – by Product Type

1.3.2 Middle East & Africa Biopharmaceuticals Market – by Application

1.3.3 Middle East & Africa Biopharmaceuticals Market – by Country

2. Middle East & Africa Biopharmaceuticals Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Biopharmaceuticals Market – Market Landscape

4.1 Overview

4.2 Middle East & Africa PEST Analysis

4.3 Expert’s Opinion

5. Middle East & Africa Biopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Application in Cancer Therapeutics

5.1.2 Potential to Treat Rare Diseases

5.2 Market Restraints

5.2.1 High Cost of Manufacturing Infrastructure

5.3 Market Opportunities

5.3.1 Accelerated Clinical Trials

5.4 Future Trends

5.4.1 Contract Manufacturing of Biopharmaceuticals

5.5 Impact Analysis

6. Biopharmaceuticals Market – Middle East & Africa Analysis

6.1 Middle East & Africa Biopharmaceuticals Market Revenue Forecast and Analysis

7. Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 – by Product Type

7.1 Overview

7.2 Middle East & Africa Biopharmaceuticals Market Revenue Share, by Product Type 2021 & 2028 (%)

7.3 Monoclonal Antibodies

7.3.1 Overview

7.3.2 Monoclonal Antibodies: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Recombinant Vaccines

7.4.1 Overview

7.4.2 Recombinant Vaccines: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Cancer Vaccine

7.4.2.1.1 Overview

7.4.2.1.2 Cancer Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Malaria Vaccine

7.4.2.2.1 Overview

7.4.2.2.2 Malaria Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.3 Ebola Vaccine

7.4.2.3.1 Overview

7.4.2.3.2 Ebola Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.4 Hepatitis-B Vaccine

7.4.2.4.1 Overview

7.4.2.4.2 Hepatitis-B Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.5 Tetanus Vaccine

7.4.2.5.1 Overview

7.4.2.5.2 Tetanus Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.6 Diphtheria Vaccine

7.4.2.6.1 Overview

7.4.2.6.2 Diphtheria Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.7 Cholera Vaccine

7.4.2.7.1 Overview

7.4.2.7.2 Cholera Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.8 Others

7.4.2.8.1 Overview

7.4.2.8.2 Others: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Conventional Vaccines

7.5.1 Overview

7.5.2 Conventional Vaccines: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Polio Vaccine

7.5.2.1.1 Overview

7.5.2.1.2 Polio Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Pox Vaccine

7.5.2.2.1 Overview

7.5.2.2.2 Pox Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Other Conventional Vaccine

7.5.2.3.1 Overview

7.5.2.3.2 Other Conventional Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Recombinant Growth Factors

7.6.1 Overview

7.6.2 Recombinant Growth Factors: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.1 Erythropoietin

7.6.2.1.1 Overview

7.6.2.1.2 Erythropoietin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.2 Granulocyte Colony Stimulating Factor

7.6.2.2.1 Overview

7.6.2.2.2 Granulocyte Colony Stimulating Factor: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Purified Proteins

7.7.1 Overview

7.7.2 Purified Proteins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.1 Leukemia Inhibitory Factor (LIF)

7.7.2.1.1 Overview

7.7.2.1.2 Leukemia Inhibitory Factor (LIF): Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.2 P53 Protein

7.7.2.2.1 Overview

7.7.2.2.2 P53 Protein: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.3 P38 Protein

7.7.2.3.1 Overview

7.7.2.3.2 P38 Protein: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.4 Other Purified Proteins

7.7.2.4.1 Overview

7.7.2.4.2 Other Purified Proteins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Recombinant Proteins

7.8.1 Overview

7.8.2 Recombinant Proteins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8.2.1 Serum Albumin

7.8.2.1.1 Overview

7.8.2.1.2 Serum Albumin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8.2.2 Amyloid Protein

7.8.2.2.1 Overview

7.8.2.2.2 Amyloid Protein: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8.2.3 Defensin

7.8.2.3.1 Overview

7.8.2.3.2 Defensin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8.2.4 Transferrin

7.8.2.4.1 Overview

7.8.2.4.2 Transferrin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Recombinant Hormones

7.9.1 Overview

7.9.2 Recombinant Hormones: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.9.2.1 Recombinant Human Growth Hormones

7.9.2.1.1 Overview

7.9.2.1.2 Recombinant Human Growth Hormones: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.9.2.2 Recombinant Insulin

7.9.2.2.1 Overview

7.9.2.2.2 Recombinant Insulin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.9.2.3 Other Recombinant Hormones

7.9.2.3.1 Overview

7.9.2.3.2 Other Recombinant Hormones: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10 Recombinant Enzymes

7.10.1 Overview

7.10.2 Recombinant Enzymes: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10.2.1 Enterokinase

7.10.2.1.1 Overview

7.10.2.1.2 Enterokinase: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10.2.2 Cyclase

7.10.2.2.1 Overview

7.10.2.2.2 Cyclase: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10.2.3 Caspase

7.10.2.3.1 Overview

7.10.2.3.2 Caspase: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10.2.4 Cathepsin

7.10.2.4.1 Overview

7.10.2.4.2 Cathepsin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.11 Cell and Gene Therapies

7.11.1 Overview

7.11.2 Cell and Gene Therapies: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.11.2.1 Allogenic Products

7.11.2.1.1 Overview

7.11.2.1.2 Allogenic Products: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.11.2.2 Autologous Products

7.11.2.2.1 Overview

7.11.2.2.2 Autologous Products: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.11.2.3 Acellular Products

7.11.2.3.1 Overview

7.11.2.3.2 Acellular Products: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.12 Cytokines/Interferon/Interleukins

7.12.1 Overview

7.12.2 Cytokines/Interferon/Interleukins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.13 Others (mRNA Based Therapeutics, etc.)

7.13.1 Overview

7.13.2 Others (mRNA Based Therapeutics, etc.): Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Biopharmaceuticals Market Analysis and Forecasts to 2028 – by Application

8.1 Overview

8.2 Middle East & Africa Biopharmaceuticals Market, by Application 2021 & 2028 (%)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Inflammatory and Infectious Diseases

8.4.1 Overview

8.4.2 Inflammatory and Infectious Diseases: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Autoimmune Disorders

8.5.1 Overview

8.5.2 Autoimmune Disorders: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Metabolic Disorders

8.6.1 Overview

8.6.2 Metabolic Disorders: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Hormonal Disorders and Growth Failure

8.7.1 Overview

8.7.2 Hormonal Disorders and Growth Failure: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Cardiovascular Diseases

8.8.1 Overview

8.8.2 Cardiovascular Diseases: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Neurological Diseases

8.9.1 Overview

8.9.2 Neurological Diseases: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Other Therapeutic Applications

8.10.1 Overview

8.10.2 Other Therapeutic Applications: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 – Country Analysis

9.1 Overview

9.1.1 Overview

9.1.2 Middle East & Africa: Biopharmaceuticals Market, by Country, 2021 & 2028 (%)

9.1.2.1 UAE: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.1 UAE: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.2.1.1.1 UAE: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.2.1.1.2 UAE: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.2.1.1.3 UAE: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.2.1.1.4 UAE: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.2.1.1.5 UAE: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.2.1.1.6 UAE: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.2.1.1.7 UAE: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.2.1.1.8 UAE: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.2.1.2 UAE: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

9.1.2.2 Saudi Arabia: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.1 Saudi Arabia: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.2.2.1.1 Saudi Arabia: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.2.2.1.2 Saudi Arabia: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.2.2.1.3 Saudi Arabia: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.2.2.1.4 Saudi Arabia: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.2.2.1.5 Saudi Arabia: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.2.2.1.6 Saudi Arabia: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.2.2.1.7 Saudi Arabia: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.2.2.1.8 Saudi Arabia: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.2.2.2 Saudi Arabia: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

9.1.2.3 South Africa: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.1 South Africa: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.2.3.1.1 South Africa: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.2.3.1.2 South Africa: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.2.3.1.3 South Africa: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.2.3.1.4 South Africa: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.2.3.1.5 South Africa: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.2.3.1.6 South Africa: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.2.3.1.7 South Africa: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.2.3.1.8 South Africa: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.2.3.2 South Africa: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

9.1.2.4 Rest of Middle East & Africa: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.4.1 Rest of Middle East & Africa: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.2.4.1.1 Rest of Middle East & Africa: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.2.4.1.2 Rest of Middle East & Africa: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.2.4.1.3 Rest of Middle East & Africa: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.2.4.1.4 Rest of Middle East & Africa: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.2.4.1.5 Rest of Middle East & Africa: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.2.4.1.6 Rest of Middle East & Africa: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.2.4.1.7 Rest of Middle East & Africa: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.2.4.1.8 Rest of Middle East & Africa: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.2.4.2 Rest of Middle East & Africa: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

10. Middle East & Africa Biopharmaceuticals Market – Industry Landscape

10.1 Overview

10.2 Organic Growth Strategies

10.2.1 Overview

10.3 Inorganic Growth Strategies

10.3.1 Overview

11. Company Profiles

11.1 Amgen Inc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 AbbVie Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Eli Lilly and Co

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Bristol-Myers Squibb Co

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Johnson & Johnson

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Boehringer Ingelheim International GmbH

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Thermo Fisher Scientific Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 AGC Biologics AS

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Lonza Group AG

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Table 2. UAE Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. UAE Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 4. UAE Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 5. UAE Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 6. UAE Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 7. UAE Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 8. UAE Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 9. UAE Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 10. UAE Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 11. UAE Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12. Saudi Arabia Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. Saudi Arabia Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 14. Saudi Arabia Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 15. Saudi Arabia Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 16. Saudi Arabia Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 17. Saudi Arabia Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 18. Saudi Arabia Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 19. Saudi Arabia Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 20. Saudi Arabia Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 21. Saudi Arabia Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 22. South Africa Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 23. South Africa Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 24. South Africa Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 25. South Africa Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 26. South Africa Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 27. South Africa Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 28. South Africa Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 29. South Africa Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 30. South Africa Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 31. South Africa Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Middle East & Africa Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Middle East & Africa Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 34. Rest of Middle East & Africa Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 35. Rest of Middle East & Africa Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 36. Rest of Middle East & Africa Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 37. Rest of Middle East & Africa Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 38. Rest of Middle East & Africa Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 39. Rest of Middle East & Africa Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 40. Rest of Middle East & Africa Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 41. Rest of Middle East & Africa Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 42. Recent Organic Growth Strategies in Biopharmaceuticals Market

Table 43. Recent Inorganic Growth Strategies in the Middle East & Africa biopharmaceuticals market

Table 44. Glossary of Terms

LIST OF FIGURES

Figure 1. Middle East & Africa Biopharmaceuticals Market Segmentation

Figure 2. Middle East & Africa Biopharmaceuticals Market, by Country

Figure 3. Middle East & Africa Biopharmaceuticals Market Overview

Figure 4. Monoclonal Antibodies Segment Held Largest Share of Product Type Segment in Middle East & Africa Biopharmaceuticals Market

Figure 5. Saudi Arabia Expected to Show Remarkable Growth During Forecast Period

Figure 6. Middle East & Africa: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. Middle East & Africa Biopharmaceuticals Market: Impact Analysis of Drivers and Restraints

Figure 9. Middle East & Africa Biopharmaceuticals Market – Revenue Forecast and Analysis – 2020–2028

Figure 10. Middle East & Africa Biopharmaceuticals Market Revenue Share, by Product Type 2021 & 2028 (%)

Figure 11. Monoclonal Antibodies: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Recombinant Vaccines: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Cancer Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Malaria Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Ebola Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Hepatitis-B Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Tetanus Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Diphtheria Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Cholera Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Others: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Conventional Vaccines: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Polio Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Pox Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Other Conventional Vaccine: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Recombinant Growth Factors: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Erythropoietin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Granulocyte Colony Stimulating Factor: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Purified Proteins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Leukemia Inhibitory Factor (LIF): Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. P53 Protein: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. P38 Protein: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Other Purified Proteins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Recombinant Proteins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Serum Albumin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Amyloid Protein: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Defensin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Transferrin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Recombinant Hormones: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Recombinant Human Growth Hormones: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Recombinant Insulin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Other Recombinant Hormones: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Recombinant Enzymes: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Enterokinase: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. Cyclase: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Caspase: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Cathepsin: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. Cell and Gene Therapies: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Allogenic Products: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. Autologous Products: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. Acellular Products: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51. Cytokines/Interferon/Interleukins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52. Others (mRNA Based Therapeutics, etc.): Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 53. Middle East & Africa Biopharmaceuticals Market, by Application 2021 & 2028 (%)

Figure 54. Oncology: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 55. Inflammatory and Infectious Diseases: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 56. Autoimmune Disorders: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 57. Metabolic Disorders: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 58. Hormonal Disorders and Growth Failure: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59. Cardiovascular Diseases: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60. Neurological Diseases: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61. Other Therapeutic Applications: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 62. Middle East & Africa: Biopharmaceuticals Market, by Key Country – Revenue (2021) (US$ Million)

Figure 63. UAE: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 64. Saudi Arabia: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 65. South Africa: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 66. Rest of Middle East & Africa: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)